I

Instituto de Oncologia de Sorocaba | Sorocaba, Brazil

Research site

(Unclaimed)

Location

Avenida Comendador Pereira Inacio, 950, sorocaba, São Paulo, Brazil

Site insights

Top conditions

Top treatments

cyclophosphamide

Tislelizumab

Zipalertinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)

This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzum...

Active, not recruiting

Gastroesophageal Adenocarcinoma

Gastric Neoplasms

Drug: Tislelizumab

Drug: Capecitabine

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection (REZILIENT4)

The purpose of this study is to compare the efficacy of zipalertinib versus placebo in participants with early stage resected non-small cell lung can...

Active, not recruiting

NSCLC, Early Stage

Exon 20

Drug: TAS6417

Drug: Zipalertinib Matching-placebo

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms